Table 3 Safety analysis. Adverse events and use of other medications (n). Data is expressed as numbers, (%) of patients
|  | CAD Group (n = 76) | The Control Group (n = 78) | p value |
|---|---|---|---|
Intraoperative adverse events, n (%) | 14 (18.42) | 27 (34.62) | * 0.023 |
  Chocking cough | 4 (5.26) | 14 (17.95) | *0.014 |
  Hiccup | 5 (6.58) | 5 (6.41) | 1.000 |
  Moving | 1 (1.32) | 5 (6.41) | 0.224 |
  Hypertension | 0 | 0 | - |
  Arrhythmia | 2 (2.63) | 1 (1.28) | 0.982 |
  Hypoxemia | 1 (1.32) | 1 (1.28) | 1.000 |
  Hypotension | 1 (1.32) | 1 (1.28) | 1.000 |
Postoperative adverse events, n (%) | 1 (1.32) | 2 (2.56) | 1.000 |
  Dizziness | 0 | 0 | - |
  Nausea | 0 | 1 (1.28) | 1.000 |
  Respiratory depression | 0 | 0 | - |
  Dysphoria | 0 | 0 | - |
  Hypoxemia | 1 (1.32) | 1 (1.28) | 1.000 |
Use of other medications, n (%) | 2 (2.63) | 3 (3.84) | 1.000 |
  Phenylephrine | 1 (1.32) | 1(1.28) | 1.000 |
  Atropine | 0 | 1(1.28) | 1.000 |
  Dopamine | 0 | 1 (1.28) | 1.000 |
  Methoxamine hydrochloride | 1 (1.32) | 0 | 0.494 |